Personalized treatments have great potential to defeat cancer cells. Guided selection of the most suitable drug or combination of drugs for a specific patient’s cancer profile and genetics avoids a trial-and-error treatment strategy and minimizes collateral effects. By screening small, dedicated drug libraries on biopsy-derived primary tumor cells, the drugs that elicit the best response can be identified.
Download this eBook to learn more about:
Technology Networks Limited
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK
© 2021 Technology Networks
All rights reserved
Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy